Pharmacological Inhibition of WIP1 Sensitizes Acute Myeloid Leukemia Cells to the MDM2 Inhibitor Nutlin-3a.

Finally, WIP1 protein showed a trend towards increased expression after Nut-3a treatment in the TP53 -wt cells, ( Figure 4 C and Figure S3 ), while being downmodulated by the drugs and their combination in NOMO1 cells ( Figure 4 D and Figure S3 ). 3.5.

also in 53,322 other papers